You may need to download additional plug-ins to open this file.
- Understanding the enemy: Staphylococcus aureus, Clostridium difficile, targeting the bad guys, and encouraging the good guys
- How bacteria respond to antibiotics and develop resistance: assessing the threat of new resistant strains, cell wall defences and multi-drug pumps, on the defensive, and unravelling the mysterious resistance of the bacteria that cause TB
- Towards new treatments: new lease of life for penicillins, harnessing nature's antibiotic factories, a treatment from bullfrogs, EU consortium for antibiotic research, mupirocins, using weapons from viruses that kill bacteria, antimicrobial coatings, and new target for novel therapeutics
- New companies take up the fight: ABsynth Biologics, Inspiralis Ltd, Novacta Biosystems Ltd, Procarta Biosystems Ltd, and Prolysis